Ron Margolis is an Ophthalmology physician. OpenAlex indexes 81 publications with 5,164 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
191 Main St
Manchester, CT 060423556
Telephone
860-646-7704Provider last certified this registry record 28 Jun 2021.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurotech Pharmaceuticals, Inc.Program year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
- Ocular Therapeutix, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
88.6%Antineovascularisation agents85%Faricimab-svoa100%Part B, office-administered≥157 patientsAminoglycoside Antibacterial1.1%Neomycin-Polymyxin-Dexameth96%Tobradex4%Part D≥386 patients+ 9 more classes in this area
Cancer & immunology
10.8%Complement Inhibitor6.6%Pegcetacoplan100%Part B, office-administered≥61 patientsVascular Endothelial Growth Factor Inhibitor4.2%Aflibercept100%Part B, office-administered≥321 patientsNervous system
0.2%Opioid Agonist0.1%Oxycodone Hcl100%Part D≥54 patientsBenzodiazepine0.1%Alprazolam100%Part D≥30 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- DataMed – an open source discovery index for finding biomedical datasets
Journal of the American Medical Informatics Association
2017
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”